Kava treatment in patients with anxiety.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/15162364
Conclusion of this study
It can be concluded that the applied 150 mg WS 1490 per day is an effective and safe treatment of non-psychotic anxiety syndromes in the described population.
Supplements analyzed in this study
|
Health conditions analyzed in this study
|
||
|
Functions related to this study
|
||
|
Body systems related to this study
 Nervous System |
